Trend in approval of targeted biologics in the last two decades
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2024.
Автор: | Siddika, Khadiza |
---|---|
Інші автори: | Ahmed, Syeda Maliha |
Формат: | Дисертація |
Мова: | English |
Опубліковано: |
Brac University
2024
|
Предмети: | |
Онлайн доступ: | http://hdl.handle.net/10361/24296 |
Схожі ресурси
-
Targeted therapeutic options in the treatment of Breast Cancer
за авторством: Alam, Kazi Tasnuva
Опубліковано: (2022) -
Study on anticancer drugs approved by the FDA from 2014 to 2023
за авторством: Rattry, Faria Rahman
Опубліковано: (2024) -
Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
за авторством: Tania, Umme
Опубліковано: (2023) -
RIPK pathway, as a potential target, for cancer treatment - a review
за авторством: Jahan, Nusrat
Опубліковано: (2024) -
Molecular biology : genes to proteins /
за авторством: Tropp, Burton E.
Опубліковано: (2008)